그누보드5

본문 바로가기
사이트 내 전체검색
HISTORY

About Us.

2018

01.

Anti-cancer drug BEY1107: applied for IND for phase I/II clinical trial

Approved as venture company (Venture capital association)

02.

Anti-cancer drug BEY1107: IND approved for phase I/II clinical trial

04.

Granted from Ministry of Health and Welfare (MOHW) (2 year)

Series C investment raised (allotment to third party)

05.

Anti-cancer drug BEY1107: begins phase I/II clinical trial

2017

01.

Anti-Alzheimer drug BEY2153: entered into non-clinical study (GLP)

BEY4101: entered into non-clinical study (GLP)

04.

Granted from Ministry of Science and ICT (MSIT) (5 year)

08.

Applied for patent in major foreign countries

09.

Domestic product patent registered

12.

Industrial land allotted at International Science Business Belt (Dungok district)

2016

06.

Anti-cancer drug BEY1107: completed non-clinical study (GLP)

Series B investment raised (allotment to third party)

2015

01.

Anti-cancer drug BEY1107: entered into non-clinical study (GLP)

06.

Granted from Ministry of Science and ICT (MSIT) (5 year)

12.

Approved as venture company (Venture capital association)

2014

03.

Approved as company-affiliated R&D center

05.

Granted from Small Medium Business Administration (SMBA)

06.

Series A investment raised (allotment to third party)

08.

Granted from Daejeon Technopark

11.

Granted from Small Medium Business Administration (SMBA)

12.

Granted from Ministry of Science and ICT (MSIT) (2 year)

2013

06.

Founded BeyondBio Inc.

11.

Approved as Research & Development Dedicated Department

12.

Approved as venture company (Korea Technology Finance Corporation)

회원로그인

접속자집계

오늘
103
어제
405
최대
898
전체
148,305
그누보드5
Copyright © 소유하신 도메인. All rights reserved.